naltrexone has been researched along with Narcotic Bowel Syndrome in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 23 (88.46) | 2.80 |
| Authors | Studies |
|---|---|
| Israel, RJ; Mehta, N; Slatkin, NE; Stambler, N | 1 |
| Chiba, H; Fujita, M; Hasegawa, M; Kitaura, M; Kobayashi, M; Koike, K; Mishima, H; Morioka, Y; Suzuki, T; Takenouchi, S; Yasufuku, K | 1 |
| Fujita, Y; Hiruta, E; Imai, H; Ito, M; Kamiya, T; Koizuka, S; Kotake, M; Masuno, T; Matsuura, M; Minato, K; Mogi, J; Nishiba, H; Takei, S; Tanaka, H; Yamazaki, S | 1 |
| Israel, RJ; Peacock, WF; Slatkin, NE; Stambler, N | 1 |
| Abe, H; Fushimi, K; Inoue, R; Matsui, H; Sumitani, M; Uchida, K; Yasunaga, H | 1 |
| Hashimoto, S; Honda, K; Nakazawa, M; Takata, K | 1 |
| Dewey, WL; Gillespie, JC; Huang, B; Klongkumnuankarn, P; Li, M; Mendez, RE; Selley, DE; Stevens, DL; Zhang, Y | 1 |
| Arai, K; Fujita, Y; Hiruta, E; Imai, H; Kaira, K; Kamiya, T; Masuno, T; Minato, K; Mogi, J; Nishiba, H; Sandoh, M; Takei, S; Tanaka, H; Yamazaki, S | 1 |
| Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V | 1 |
| DeGrado, JR; Dube, KM; Goodberlet, MZ; Habeeb, EA; Lupi, KE; Tran, LK | 1 |
| Ishizuka, Y; Kanbayashi, Y; Sawa, S; Shimizu, M; Uchida, M; Yabe, K | 1 |
| Brown, B; Price, ST | 1 |
| Muttini, S; Palandri, C; Racagni, M; Umbrello, M; Venco, R | 1 |
| Ashizawa, K; Hara, T; Ikeda, T; Ishii, K; Kamada, M; Komatsu, Y; Matsuo, K; Morishita, S; Ryu, E; Yamaguchi, M; Yamashita, H | 1 |
| Davis, AM; Micic, D; Rao, VL | 1 |
| Chamberlain, BH; Israel, RJ; Rhiner, M; Slatkin, NE; Stambler, N | 1 |
| Anjum, A; Brett, SJ; Cross, M; Gordon, AC; O'Callaghan, D; Patel, PB; Warwick, J | 1 |
| Hale, M; Webster, L; Wild, J; Yamada, T | 1 |
| Higurashi, T; Honda, Y; Ichikawa, Y; Imajo, K; Ishiki, H; Iwaki, M; Kato, T; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Ogawa, Y; Ozaki, A; Saito, S; Taguri, M; Yamanaka, T; Yoneda, M; Yoshihara, T | 1 |
| Brenner, DM; Liu, JJ; Quinton, SE | 1 |
| Brocklebank, J; Fingas, S; Miller, EJ | 1 |
| Berger, AA; Clay, CJ; Hasoon, J; Jung, JW; Kassem, H; Kaye, AD; Kaye, AM; Kiernan, HC; Monteferrante, N; Patel, A; Urits, I; Viswanath, O | 1 |
| Liao, SS; Slatkin, NE; Stambler, N | 1 |
| Amaya, F; Ishikawa, T; Kanbayashi, Y; Tabuchi, Y; Taguchi, T; Takayama, K; Ueno, H | 1 |
| Brenner, DM; Burr, NE; Ford, AC; Luthra, P | 1 |
| Arai, T; Chiba, H; Hasegawa, M; Horita, N; Kanemasa, T; Kihara, T; Koike, K; Morioka, Y; Nakamura, A; Ono, H | 1 |
6 review(s) available for naltrexone and Narcotic Bowel Syndrome
| Article | Year |
|---|---|
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
Topics: Aged; Analgesics, Opioid; Constipation; Humans; Male; Naltrexone; Opioid-Induced Constipation; Quaternary Ammonium Compounds | 2022 |
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Topics: Adult; Analgesics, Opioid; Child; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Oxycodone; Palliative Care; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome | 2022 |
Peripherally-active mu-opioid receptor antagonists for constipation in critically ill patients receiving opioids: A case-series and a systematic review and meta-analysis of the literature.
Topics: Adult; Analgesics, Opioid; Constipation; Critical Illness; Humans; Laxatives; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Retrospective Studies | 2023 |
Naldemedine for the treatment of opioid-induced constipation in adults with chronic noncancer pain.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Constipation; Humans; Naltrexone; Opioid-Induced Constipation | 2020 |
Naldemedine for the Use of Management of Opioid Induced Constipation.
Topics: Analgesics, Opioid; Constipation; Humans; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation | 2020 |
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.
Topics: Analgesics, Opioid; Gastrointestinal Agents; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Randomized Controlled Trials as Topic | 2019 |
5 trial(s) available for naltrexone and Narcotic Bowel Syndrome
| Article | Year |
|---|---|
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Constipation; Double-Blind Method; Humans; Naltrexone; Opioid-Induced Constipation; Quaternary Ammonium Compounds; Treatment Outcome | 2021 |
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
Topics: Adult; Aged; Cancer Pain; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Induced Constipation; Outcome Assessment, Health Care; Quaternary Ammonium Compounds | 2020 |
Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.
Topics: Adult; Analgesics, Opioid; Constipation; Critical Care; Humans; Naltrexone; Opioid-Induced Constipation; Quaternary Ammonium Compounds | 2020 |
Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.
Topics: Analgesics, Opioid; Clinical Trials, Phase II as Topic; Defecation; Humans; Japan; Magnesium Oxide; Naltrexone; Neoplasms; Opioid-Induced Constipation; Proof of Concept Study; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
Topics: Age Factors; Aged; Analgesics, Opioid; Constipation; Humans; Naltrexone; Opioid-Induced Constipation; Quaternary Ammonium Compounds; Treatment Outcome | 2021 |
15 other study(ies) available for naltrexone and Narcotic Bowel Syndrome
| Article | Year |
|---|---|
Involvement of the Peripheral μ-Opioid Receptor in Tramadol-Induced Constipation in Rodents.
Topics: Analgesics, Opioid; Animals; Intestine, Small; Male; Naltrexone; Nociception; Opioid-Induced Constipation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, mu; Tramadol | 2021 |
Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study.
Topics: Analgesics, Opioid; Constipation; Humans; Naltrexone; Neoplasms; Opioid-Induced Constipation; Retrospective Studies | 2021 |
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid-induced constipation: A nationwide retrospective cohort study in Japan.
Topics: Analgesics, Opioid; Constipation; Delirium; Humans; Ileus; Incidence; Japan; Naltrexone; Neoplasms; Opioid-Induced Constipation; Retrospective Studies | 2022 |
Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan.
Topics: Analgesics, Opioid; Cancer Pain; Constipation; Humans; Japan; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Product Surveillance, Postmarketing; Prospective Studies | 2022 |
Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment.
Topics: Analgesics, Opioid; Constipation; Humans; Ligands; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Receptors, Opioid, mu | 2022 |
A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients.
Topics: Analgesics, Opioid; Constipation; Humans; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Prospective Studies; Retrospective Studies; Thoracic Neoplasms | 2022 |
Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
Topics: Adult; Analgesics, Opioid; Constipation; Critical Illness; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Pain; Prospective Studies; Quaternary Ammonium Compounds; Retrospective Studies | 2023 |
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
Topics: Analgesics, Opioid; Constipation; Gastrointestinal Agents; Humans; Morphinans; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Quality of Life; Retrospective Studies | 2022 |
Mu-Opioid Antagonists for the Treatment of Opioid-Induced Bowel Dysfunction.
Topics: Analgesics, Opioid; Constipation; Humans; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation | 2023 |
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Oxycodone; Substance Withdrawal Syndrome | 2020 |
Medical Management of Opioid-Induced Constipation.
Topics: Analgesics, Opioid; Humans; Laxatives; Lubricants; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Polyethylene Glycols | 2019 |
Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age.
Topics: Aged; Aged, 80 and over; Chronic Pain; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Safety | 2020 |
Naloxegol rescue with methylnaltrexone highly effective.
Topics: Analgesics, Opioid; Female; Humans; Middle Aged; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Palliative Care; Polyethylene Glycols; Quality of Life; Quaternary Ammonium Compounds | 2020 |
Factors affecting the effect of naldemedine for opioid-induced constipation: a single-institution, retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cholinergic Antagonists; Chronic Pain; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Retrospective Studies; Time Factors; Tramadol; Treatment Outcome; Young Adult | 2021 |
Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation.
Topics: Animals; Gastrointestinal Motility; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Rats | 2019 |